INTRODUCTION
Colon cancer is one of the most commonly diagnosed causes of premature mortality in people of developed countries [1] [2] [3] . Tumors present in the lining of the colon are the main cause of deaths associated with cancer in the United States [4] . Adoption of westernized dietary patterns has greatly increased the incidence of colon cancer in Asian people [5] .
Cellular apoptosis maintains homeostasis in living organisms by destroying unwanted cells via both extrinsic and intrinsic pathways [6] . In the extrinsic apoptotic pathway, receptors on the cell surface activate caspase-8 [7] , whereas in the intrinsic apoptotic pathway, various types of cellular stimuli change the expression levels of members of the Bcl-2 family, leading to the release of cytochrome c [7] .
The process of cellular apoptosis is evident by changes in cellular morphology, such as altered membrane shape, cell shrinkage, lower mitochondrial membrane potential, nuclear material condensation, and fragmentation of double-stranded DNA [8, 9] . In various types of carcinomas, such as of the colon, liver, and pancreas, the expression levels of peroxisome proliferator-activated receptor γ (PPARγ) increase [10] . Studies have shown that PPARγ is associated with the regulation of various processes associated with inflammation [11] . The inflammatory responses induced by nuclear factor-κB (NF-κB) are suppressed by PPARγ and its upstream activators. It has been reported that PPARγ activation, after exposure to punicic acid, inhibits the inflammation of intestinal tissues in mouse [12] . The expression of genes associated with the inhibition of inflammation is suppressed by PPARγ by the targeting of various factors such as NF-κB, p65, and p50 [13] .
Natural products isolated during phytochemical investigations have demonstrated promising potential in inhibiting tumor development and progression by stimulating cellular apoptosis [14, 15] . For example, triptolide, which was isolated during the phytochemical investigation of Tripterygium wilfordii Hook F, is a complex diterpenoid molecule [16] [17] [18] . Biological investigations of triptolide have revealed its potential as a suppressor of the immune system, an anticancer agent, and a contraceptive [16] [17] [18] . Triptolide treatment of cancer cells induces apoptosis via cytochrome c release, damages mitochondria, and suppresses antiapoptotic protein expression [19] .
In the present study, the growth inhibitory effects of triptolide on colon cancer cells and on tumor development in an azoxymethane/dextran sulfate sodium (AOM/DSS) mouse model were investigated. The results demonstrate that triptolide treatment of colon cancer cells reduces viability, induces apoptosis, and suppresses tumor development by inhibiting inflammation.
EXPERIMENTAL Chemicals
Triptolide obtained from Sigma-Aldrich Co. (St. Louis, MO) was dissolved in dimethylsulfoxide to prepare the stock solution. Various concentrations of triptolide were prepared at the time of use in experiment. A colonic carcinogen azoxymethane (AOM) was purchased from Sigma-Aldrich. Dextran sulfate sodium (DSS) with a molecular weight of 36, 000 -50, 000 (cat. no. 160110) was purchased from MP Biomedicals, LLC (Aurora, OH).
Cell culture
HCT116 colon cancer cells were purchased from Shanghai Institute of Biochemistry and Cellular Biology Chinese Academy of Sciences (Shanghai, China). The cells were cultures in Dulbecco's modified Eagle's medium (DMEM; Gibco Life Technologies, Carlsbad, CA, USA) containing 10 % fetal bovine serum. Antibiotics such as penicillin (100 U/ml) and streptomycin (100 U/ml) were also added to the medium. Culture of cells was performed at 37 o C in an incubator with humidified atmosphere of 5 % CO 2 and 95 % air.
MTT assay
HCT116 and DLD-1 cells after culture in Dulbecco's modified Eagle's medium (DMEM; Gibco Life Technologies, Carlsbad, CA, USA) for 24 h were incubated with various doses of triptolide for 72 h. MTT (3-(4, 5-dimethylthiazol2-yl)-2, 5-diphenyltetrazolium bromide, 5 mg/ml) 20 µl was put into each of the well of 96-well plates and then incubation was continued for 4 h more. Following decantation of medium 150 µl of Write in full the first time with the abbreviation in brackets was put into each well of the plate. Absorbance was recorded for each well three times by multi-well reader at a wavelength of 490 nm to determine the cell viability.
Flow cytometry

HCT116 cells (2 x 10
5 cells per ml) after incubation with various doses of triptolide were collected, washed with PBS three times and then treated with binding buffer. Then 5 µl each of annexin-V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) were added to cells and the cells were subjected to 15 min incubation under dark atmosphere at room temperature. FACScalibur Flow Cytometer (BD Biosciences, San Jose, CA, USA) was used for the analysis of induction of apoptotic changes in the cells.
Western blot analysis
HCT116 cells were subjected to incubation with various doses of triptolide for 72 h. The cells were then collected and lysed on treatment with lysis buffer followed by measurement of protein concentration in the supernatant (Pierce, Rockford, IL). The protein separation was achieved using 10 % sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were transferred onto the nitrocellulose membrane and subsequently incubated with primary antibodies against NF-κB, PPARγ, pIκBα, iNOS, p50, p65, MMP-2, MMP-9 and β-actin (all Wuhan Boster Biological Technology, Ltd., Wuhan, China; 1: 1, 000). After incubation the membranes were washed and then incubated with horseradish peroxidaseconjugated secondary antibodies (Wuhan Boster Biological Technology, Ltd.; 1: 10, 000). The complexes formed by interaction of antigen and antibody were analyzed using the enhanced chemiluminescence (ECL) detection system (GE Healthcare Biosciences, Pittsburgh, PA).
Analysis of migration potential
For the measurement of HCT116 cell migration 24-well Boyden chamber (Corning, Tewksbury, MA) was used. Into the inserts of upper compartment of the Trans well chamber HCT116 cells were put at a density of 5 x 10 5 cells per 100 µl in the medium devoid of serum. The lower chamber contained 600 µl RPMI 1640 supplemented with 10 % FBS. Migration of the cells was allowed for 72 h under conditions of 37 o C temperature and in an atmosphere of 5 % CO 2 . Gentle rubbing was performed to remove the cells that did not migrate using cotton swab. The migrated cells on the lower surface PBS washed and then fixed using methyl alcohol. The cells were then subjected to crystal violet staining followed by measurement of optical density three times independently at 570 nm wavelength.
Animals
Institute of Cancer Research strain (ICR) of mice twenty five in number and seven week old were supplied by the Experimental Animal Centre of Zhejiang University (Hangzhou, China). In the animal facility center housing was done under diurnal lighting conditions with 12 h dark and light cycles and were provided free access to water and food. The temperature in the animal facility centre was maintained ~25 ˚C and humidity adjusted to (55 ± 10 %). The animals were acclimatized to laboratory atmosphere for seven days before the start of the experiment.
Ethical statement
The protocol for the study on animals was appro- Research by the American Psychological Association [20] .
Animal studies
An aqueous solution of dextran sulfate sodium (1.5 % w/v) was prepared for inducing colitis in. The animals were divided into five groups of five mice each. The normal control group were given saline, animals in the untreated control group received AOM and DSS whereas animals in the treatment groups received 10, 50 and 100 mg/kg doses of triptolide intraperitoneally alternately for 2 months after AOM and DSS injection. After completion of treatment (2 months) the animals were sacrificed using sodium pentobarbital anesthesia to extract colon. The colon tissues were subjected to histopathological analysis after staining with hematoxylin and eosin (H&E).
Statistical analysis
The data obtained were processed using Statistical Package for Social Sciences for Windows, version 17.0 (SPSS, Inc, Chicago, IL, USA). Analysis of the data was performed using monofactorial analysis of variance. The data are presented as mean ± standard deviation (SD). P < 0.05 was taken as significant statistically.
RESULTS
Viability of HCT116 cells is inhibited by triptolide
Triptolide decreased the viability of HCT116 and DLD-1 cells in a dose-dependent manner. At doses of 10, 50, 100, 150, and 200 µM, triptolide decreased HCT116 cell viability by 8, 27, 53, 74, and 89 %, respectively, after 72 h of treatment ( Figure 1) . Additionally, the viability of DLD-1 cells was decreased by 11, 31, 49, 68, and 83 % after the addition of 10, 50, 100, 150, and 200 µM triptolide, respectively (Figure 1 ). 
Triptolide reduces NF-κB activity in HCT116 cells
The expression levels of NF-κB were analyzed in HCT116 cells by western blot analysis. After 72 h incubation with 200 µM triptolide, the expression of pIκBα was significantly decreased, and PPARγ activity was increased (Figure 3) . No significant increase was observed in the activity of PPARγ at either the 10-or 50-µM doses of triptolide. The levels of pIκBα, inducible nitric oxide synthetase (iNOS), p50, and p65 were also decreased after treatment with triptolide. 
Migration of HCT116 cells is reduced by triptolide
Triptolide reduced the migratory potential of HCT 116 cells after 72 h ( Figure 4A ). Compared to control cell cultures, the migratory potential of HCT116 cells was reduced significantly after a 72-h incubation with 100 µM triptolide. In addition, HCT116 cells treated with 100 µM triptolide for 72 h showed a marked reduction in the activity of both metalloproteinase-2 and metalloproteinase-9 ( Figure 4B ).
Tumor growth is inhibited by triptolide in an AOM/DSS mouse model
Untreated control AOM/DSS mice showed markedly high tissue inflammation, as shown in hematoxylin-and eosin-stained sections. On the other hand, treatment of AOM/DSS mice with 100 µM triptolide significantly prevented tissue inflammation ( Figure 5 ). The incidence of tumors in the untreated control group was significantly higher than in the triptolide-treated groups. Adenocarcinoma multiplicity in the untreated control group was 3.35 ± 0.98, which was reduced to 2.16 ± 0.56, 1.87 ± 0.46, and 0.43 ± 0.23, respectively, in mice treated with 10, 50, and 100 mg/kg triptolide.
DISCUSSION
The current study demonstrates the inhibitory effects of triptolide on colon cancer cell growth and on tumor growth in an AOM/DSS mice model. Triptolide reduced the viability of HCT116 cells via apoptotic cell death and prevented tumor growth in mice. Cell death can occur via an apoptotic or non-apoptotic pathway. Apoptosis, or programmed cell death, maintains homeostasis via either an intrinsic or extrinsic pathway [21] .
Our study revealed that triptolide reduced HCT116 cell viability through an apoptotic pathway, which was evident by nuclear material condensation. In addition, triptolide promoted the expression of cleaved PARP and decreased the expression of pro-caspase-3 and pro-caspase-8 in HCT116 cells. It is known that agonists of PPARγ inhibit colorectal tumor progression via the upregulation of genes associated with tumor suppression [22] . Such agonists are thus considered to be of great significance for the development of effective chemotherapeutic strategies for colon cancer. Active PPARγ inhibits cellular inflammatory processes by targeting gene transcription. Expression of various factors, such as iNOS, cyclooxygenase-2, etc., is associated with the upregulation of inflammatory processes that are regulated by NF-κB [23] . Colon cancer patients are reported to have high levels of active NF-κB, which stimulate tumor progression [24] . Results from the present study show that triptolide enhances PPARγ levels and reduces iNOS levels in HCT116 cells. Additionally, metalloproteinases have been shown to play important roles in promoting tumor migration and invasive potential [25] .
In HCT116 cells, triptolide increases the expression levels of molecules that promote tumor migration and invasion. The levels of both metalloproteinase-2 and metalloproteinase-9 were markedly increased after incubation of HCT116 cells with triptolide. A previous study demonstrated that active PPARγ caused the inhibition of alimentary canal inflammation; thus, its expression is of significance for the treatment of colon cancer [26] . Our study demonstrated that triptolide treatment of AOM/DSS mice significantly prevented colon tissue inflammation. Moreover, tumor incidence was significantly reduced in these mice after a 2-month treatment with triptolide.
CONCLUSION
The findings of this study show that triptolide reduces the viability of colon cancer cells via the induction of apoptosis and prevents tumor metastasis in vivo. Therefore, triptolide should be further evaluated as an effective chemotherapeutic agent for colon cancer.
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